WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009134711) HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/134711    International Application No.:    PCT/US2009/041785
Publication Date: 05.11.2009 International Filing Date: 27.04.2009
IPC:
C07K 16/18 (2006.01), A61P 27/02 (2006.01)
Applicants: GENENTECH, INC. [US/US]; 1 DNA Way South San Francisco, CA 94080 (US) (For All Designated States Except US).
HUANG, Arthur, J. [US/US]; (US) (For US Only).
KELLEY, Robert, F. [US/US]; (US) (For US Only).
LOWMAN, Henry [US/US]; (US) (For US Only).
VAN LOOKEREN CAMPAGNE, Menno [NL/US]; (US) (For US Only).
WINTER, Charles, M. [US/US]; (US) (For US Only)
Inventors: HUANG, Arthur, J.; (US).
KELLEY, Robert, F.; (US).
LOWMAN, Henry; (US).
VAN LOOKEREN CAMPAGNE, Menno; (US).
WINTER, Charles, M.; (US)
Agent: YEUNG, Bonny, G.; Genentech, Inc. 1 DNA Way, MS-49 South San Francisco, CA 94080 (US)
Priority Data:
61/048,431 28.04.2008 US
61/048,689 29.04.2008 US
Title (EN) HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
(FR) ANTICORPS ANTI-FACTEUR D HUMANISÉS ET UTILISATIONS DE CEUX-CI
Abstract: front page image
(EN)The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
(FR)La présente invention concerne des anticorps anti-facteur D, leurs séquences d’acide nucléique et d’acides aminés, les cellules et vecteurs qui portent ces anticorps et leur production et leur utilisation dans la préparation de compositions et de médicaments pour le traitement de maladies et de troubles associés à une activation du complément excessive ou incontrôlée. Ces anticorps sont utiles pour le diagnostic, la prophylaxie et le traitement d’une maladie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)